APA

Foy K. C., Miller M. J., Moldovan N., Carson W. E. & Kaumaya P. P. T. (012013). Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060. : Oncoimmunology.

Chicago

Foy Kevin C, Miller Megan J, Moldovan Nicanor, Carson William E and Kaumaya Pravin P T. 012013. Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060. : Oncoimmunology.

Harvard

Foy K. C., Miller M. J., Moldovan N., Carson W. E. and Kaumaya P. P. T. (012013). Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060. : Oncoimmunology.

MLA

Foy Kevin C, Miller Megan J, Moldovan Nicanor, Carson William E and Kaumaya Pravin P T. Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060. : Oncoimmunology. 012013.